Avanos Medical Inc
NYSE:AVNS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Avanos Medical Inc
NYSE:AVNS
|
US |
|
R
|
Rane (Madras) Ltd
NSE:RML
|
IN |
|
Taysha Gene Therapies Inc
NASDAQ:TSHA
|
US |
|
Temple & Webster Group Ltd
ASX:TPW
|
AU |
|
Banco Macro SA
NYSE:BMA
|
AR |
|
China CSSC Holdings Ltd
SSE:600150
|
CN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AVNS's stock price target?
Not Available
AVNS doesn't have any price targets made by Wall Street professionals.
What is Avanos Medical Inc's Revenue forecast?
Projected CAGR
4%
For the last 13 years the
compound annual growth rate for
Avanos Medical Inc's revenue is
-7%.
The projected
CAGR
for the next 2 years is
4%.
What is Avanos Medical Inc's Operating Income forecast?
Projected CAGR
124%
For the last 13 years the
compound annual growth rate for
Avanos Medical Inc's operating income is
-18%.
The projected
CAGR
for the next 2 years is
124%.